Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
CEREW was delisted on the 30th of August, 2021.
22 hedge funds and large institutions have $45M invested in Cerevel Therapeutics Holdings, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 9 closing their positions.
208% more capital invested
Capital invested by funds: $14.6M → $45M (+$30.4M)
24% less funds holding
Funds holding: 29 → 22 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
+$1.17M |
| 2 |
Wolverine Trading
Chicago,
Illinois
|
+$139K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$970K |
| 2 |
GL
Governors Lane
New York
|
-$670K |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$572K |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$431K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$170K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MF
26
Magnetar Financial
Evanston,
Illinois
| – | -$170K | -38,650 | Closed |
|
|
ES
27
Equitec Specialists
Chicago,
Illinois
| – | -$154K | -35,825 | Closed |
|
|
LGM
28
Logos Global Management
San Francisco,
California
| – | -$144K | -33,333 | Closed |
|
|
AA
29
AQR Arbitrage
Greenwich,
Connecticut
| – | -$57K | -13,333 | Closed |
|
30
Verition Fund Management
Greenwich,
Connecticut
| – | -$50K | -11,809 | Closed |
|
31
Morgan Stanley
New York
| – | -$6K | -1,333 | Closed |
|
32
UBS Group
Zurich,
Switzerland
| – | -$2K | -538 | Closed |
|
CEREW Hedge Fund Activity: Q2 2021 in Review
22 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) for Q2 2021, worth a combined $45M — up 208% from $14.6M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CEREW and 2 opened new positions — a net loss of 7 holders — while 5 trimmed existing stakes and 0 added.
The largest buyer was 683 Capital Management, opening a new position worth an estimated $1.17M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $970K sold.
- 22 institutional investors held Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) as of Q2 2021, down from 29 in Q1 2021.
- Funds reported $45M of Cerevel Therapeutics Holdings, Inc. Warrant stock for Q2 2021, up 208% quarter-over-quarter.
- 2 funds opened new Cerevel Therapeutics Holdings, Inc. Warrant positions in Q2 2021 and 9 closed out, a net change of -7 holders.
- The largest Cerevel Therapeutics Holdings, Inc. Warrant buyer in Q2 2021 was 683 Capital Management, an estimated $1.17M added.
- The largest Cerevel Therapeutics Holdings, Inc. Warrant seller in Q2 2021 was Point72 Asset Management, an estimated $970K sold.
Based on aggregated 13F filings for Q2 2021.